ResMed Inc.

RMD Healthcare Medical Instruments & Supplies

ResMed Inc.’s revenue for fiscal 2026 (year ended June 2026) was $5.7 billion, up 9.85% from fiscal 2025. In the quarter to June 2026, revenue grew 8.58%, EPS grew 2.32%, free cash flow fell 21.3% and total debt fell 39.3%, each against the same quarter a year earlier. Member of the S&P 500; dividend growth for ten consecutive years, revenue growth for ten, operating cash flow growth for three.

238.97 3.26 −1.35%
Market cap
$34.1B
P/E
22.8×
Fwd P/E
16.6×
Dividend yield
1.03%
F-score
6/9
Altman Z
10.00
Beneish M
−2.59
Dividend safety
96/100

ResMed Inc. (RMD) Free cash flow

Alert me on Free cash flow

ResMed Inc.'s free cash flow for fiscal 2026 was $1.6B, unchanged from fiscal 2025. Over the past ten years it has ranged from $195.1M (fiscal 2022) to $1.7B (fiscal 2025); the current reading is higher than 92% of that period. ResMed Inc. ranks 4th of 54 Medical Instruments & Supplies companies by free cash flow.

Free cash flow, annual

Embed this chart

Annual newest first

Period Free cash flow Change
FY2026 $1.6B (1.35%)
FY2025 $1.7B 28.34%
FY2024 $1.3B 130.00%
FY2023 $559.3M 186.66%
FY2022 $195.1M (68.53%)
FY2021 $619.9M (10.98%)
FY2020 $696.3M 82.42%
FY2019 $381.7M (11.96%)
FY2018 $433.6M 26.56%
FY2017 $342.6M (28.65%)

Quarterly newest first

Period Free cash flow Change
Jun 2026 $397.4M (22.77%)
Mar 2026 $514.5M 68.60%
Dec 2025 $305.2M (25.84%)
Sep 2025 $411.5M (18.50%)
42 more quarters

Against its own ten years

Low $195.1M High $1.7B
Ten-year median $519.7M
Current reading's percentile 92

Free cash flow against peers

What Free cash flow is

Free Cash Flow tells an investor how much cash a company’s operations generate after paying for its investment in physical and intangible assets.

Operating Cash Flow + Property, Plant, Equipment Change (Net) + Intangible Assets Change (Net)

The full definition of Free cash flow →

More on RMD